integrin antagonists (University of Pennsylvania)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameintegrin antagonists (University of Pennsylvania)
Drug Alias NameDB-496CSW4-161SW4-161SB-68ASB-68B
ClassificationSmall molecules
Mechanisms of ActionCollagen inhibitorsPlatelet aggregation inhibitorsIntegrin alpha2/beta1 antagonists +[4] 
TargetsIntegrin alpha2/beta1Coagulation factorCollagen
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A